{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:45:41Z","timestamp":1791837941673,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015544","name":"King's College Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"UMCG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000404","name":"Foundation for Liver Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.rpth.2026.106975","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:36:06Z","timestamp":1789774566000},"page":"106975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-0204","authenticated-orcid":false,"given":"Fynn L.","family":"Elvers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3693-2750","authenticated-orcid":false,"given":"Jelle","family":"Adelmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-9161","authenticated-orcid":false,"given":"Marilena","family":"Stamouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-3287","authenticated-orcid":false,"given":"William","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6616-3628","authenticated-orcid":false,"given":"Vishal C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-7140","authenticated-orcid":false,"given":"Ton","family":"Lisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106975_bib1","article-title":"Rebalanced hemostasis, bleeding and thrombosis in liver disease: a comprehensive review of pathophysiology, management and future perspectives","author":"Elvers","year":"2026","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106975_bib2","first-page":"58","article-title":"Endothelium releases more von Willebrand factor and tissue-type plasminogen activator upon venous occlusion in patients with liver cirrhosis than in normals","volume":"23","author":"Tornai","year":"1993","journal-title":"Haemostasis"},{"key":"10.1016\/j.rpth.2026.106975_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/0016-5085(91)90092-Y","article-title":"A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis","volume":"101","author":"Leebeek","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rpth.2026.106975_bib4","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.30915","article-title":"Mixed fibrinolytic phenotypes in decompensated cirrhosis and acute-on-chronic liver failure with hypofibrinolysis in those with complications and poor survival","volume":"71","author":"Blasi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.rpth.2026.106975_bib5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106975_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.thromres.2022.05.004","article-title":"Incidence and prevalence of venous thromboembolism in chronic liver disease: a systematic review and meta-analysis","volume":"215","author":"Subhani","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106975_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","article-title":"Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"104","author":"Pan","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rpth.2026.106975_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13309","article-title":"Portal vein thrombosis in patients with liver cirrhosis and its impact on early and long-term outcomes after liver transplantation","volume":"73","author":"Eshraghian","year":"2019","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rpth.2026.106975_bib9","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jhep.2023.03.022","article-title":"Anticoagulation to prevent disease progression in patients with cirrhosis","volume":"79","author":"Lisman","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.rpth.2026.106975_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026863","article-title":"Prescribing trends of oral anticoagulants in US patients with cirrhosis and nonvalvular atrial fibrillation","volume":"12","author":"Simon","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2026.106975_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.dld.2018.06.003","article-title":"Management of haemostatic alterations and associated disorders in cirrhosis in Spain: a national survey","volume":"51","author":"Fortea","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.rpth.2026.106975_bib12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11739-016-1416-8","article-title":"Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry","volume":"11","author":"Violi","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.rpth.2026.106975_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10654-017-0251-1","article-title":"Lipid levels and risk of venous thrombosis: results from the MEGA-study","volume":"32","author":"Morelli","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rpth.2026.106975_bib14","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41588-019-0519-3","article-title":"Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease","volume":"51","author":"Klarin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.rpth.2026.106975_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.103004","article-title":"The role of statins in mitigating venous thromboembolism incidence and severity","volume":"9","author":"Merz","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106975_bib16","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.jtha.2023.08.004","article-title":"Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism","volume":"21","author":"Dai","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106975_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.ATV.12.1.19","article-title":"Hypertriglyceridemia and regulation of fibrinolytic activity","volume":"12","author":"Mussoni","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.rpth.2026.106975_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MBC.0b013e32835a083c","article-title":"High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals","volume":"24","author":"Z\u0105bczyk","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2026.106975_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jtha.2025.10.009","article-title":"Lipoprotein(a) prolongs ex vivo plasma clot lysis times through effects on clot formation rate and fibrin structure","volume":"24","author":"Clark","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106975_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.ATV.16.1.89","article-title":"Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL","volume":"16","author":"Sironi","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.106975_bib21","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/ATVBAHA.112.252130","article-title":"Extrahepatic high-density lipoprotein receptor SR-BI and ApoA-I protect against deep vein thrombosis in mice","volume":"32","author":"Brill","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.106975_bib22","doi-asserted-by":"crossref","first-page":"13353","DOI":"10.1021\/bi00041a011","article-title":"Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis","volume":"34","author":"Hervio","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.rpth.2026.106975_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10620-017-4862-x","article-title":"Abnormalities of lipoprotein levels in liver cirrhosis: clinical relevance","volume":"63","author":"Privitera","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rpth.2026.106975_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1194\/jlr.R119000547","article-title":"Alcohol effects on hepatic lipid metabolism","volume":"61","author":"Jeon","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.rpth.2026.106975_bib25","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.rpth.2026.106975_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jth.15112","article-title":"Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106975_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(85)90116-1","article-title":"Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man","volume":"39","author":"Saku","year":"1985","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106975_bib28","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.ATV.18.11.1679","article-title":"Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells","volume":"18","author":"Nilsson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.106975_bib29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1590\/S0100-879X1997001100004","article-title":"Apolipoprotein and lipid abnormalities in chronic liver failure","volume":"30","author":"Sp\u00f3sito","year":"1997","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.rpth.2026.106975_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MEG.0b013e3280be5ac8","article-title":"Lipoprotein profile in cirrhosis of liver","volume":"19","author":"Varghese","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.rpth.2026.106975_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0753-3322(96)82666-7","article-title":"Lipoprotein (a) and fibrinolytic system in liver cirrhosis","volume":"49","author":"Cimminiello","year":"1995","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.rpth.2026.106975_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.19.6.526","article-title":"Plasma lipids and lipoproteins in liver disease","volume":"19","author":"McIntyre","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.rpth.2026.106975_bib33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF01487639","article-title":"Serum lipids and total fatty acids in chronic alcoholic liver disease at different stages of cell damage","volume":"48","author":"Marzo","year":"1970","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.rpth.2026.106975_bib34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2008.12.024","article-title":"Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis","volume":"50","author":"Tsai","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.rpth.2026.106975_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1478-3231.2011.02657.x","article-title":"High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness","volume":"32","author":"Atogo-Asse","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.rpth.2026.106975_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/09680519050110020501","article-title":"Apolipoproteins modulate the inflammatory response to lipopolysaccharide","volume":"11","author":"Berb\u00e9e","year":"2005","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.rpth.2026.106975_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF02533630","article-title":"Hepatic triglyceride lipase deficiency in liver disease","volume":"12","author":"Freeman","year":"1977","journal-title":"Lipids"},{"key":"10.1016\/j.rpth.2026.106975_bib38","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2026.106975_bib39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.rpth.2026.106975_bib40","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1172\/JCI119751","article-title":"Cellular and molecular mechanisms of endothelial cell dysfunction","volume":"100","author":"Harrison","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2026.106975_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106975_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1612655","article-title":"Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin","volume":"85","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106975_bib43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1055\/s-0037-1616531","article-title":"The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis","volume":"86","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106975_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/ATVBAHA.114.304938","article-title":"Re-Evaluation of the anticoagulant properties of high-density lipoprotein\u2014brief report","volume":"35","author":"Fernandez","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.106975_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000292","article-title":"Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages","volume":"2","author":"Kishore","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rpth.2026.106975_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.20283","article-title":"Free fatty acids promote hepatic lipotoxicity by stimulating TNF-\u03b1 expression via a lysosomal pathway","volume":"40","author":"Feldstein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.rpth.2026.106975_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI118404","article-title":"Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide","volume":"97","author":"Samad","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2026.106975_bib48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/01.RES.85.2.208","article-title":"Very low density lipoprotein\u2013mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells","volume":"85","author":"Banfi","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.rpth.2026.106975_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.18.1.20","article-title":"Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia","volume":"18","author":"Eriksson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.106975_bib50","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1194\/jlr.P094763","article-title":"Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis","volume":"60","author":"Boffa","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.rpth.2026.106975_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/SHK.0b013e3182903f0d","article-title":"Biomarkers of endothelial cell activation in early sepsis","volume":"39","author":"Skibsted","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.rpth.2026.106975_bib52","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.jtha.2023.03.017","article-title":"In vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation","volume":"21","author":"Elvers","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106975_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcrc.2017.07.053","article-title":"Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure","volume":"43","author":"Fisher","year":"2018","journal-title":"J Crit Care"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926036332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926036332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:57:05Z","timestamp":1791835025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926036332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2475037926036332"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106975","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106975"}}